Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Cell Reports|December 31, 2022
A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75Jiandong Huo, Aiste Dijokaite-Guraliuc, Chang Liu, et al.Cell|March 17, 2021
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced seraDaming Zhou, Wanwisa Dejnirattisai, Piyada Supasa, et al.The Lancet. Microbe|November 15, 2021
T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort studyAdrienn Angyal, Stephanie Longet, Shona C Moore, et al.Wellcome Open Research|December 8, 2020
SARS-CoV-2 RNA detected in blood products from patients with COVID-19 is not associated with infectious virusMonique I Andersson, Carolina V Arancibia-Carcamo, Kathryn Auckland, et al.JCI Insight|May 24, 2022
Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronavirusesAnna L McNaughton, Robert S Paton, Matthew Edmans, et al.Cell|March 21, 2021
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine seraPiyada Supasa, Daming Zhou, Wanwisa Dejnirattisai, et al.Cell|April 14, 2021
Antibody evasion by the P.1 strain of SARS-CoV-2Wanwisa Dejnirattisai, Daming Zhou, Piyada Supasa, et al.Cell|March 23, 2021
The antigenic anatomy of SARS-CoV-2 receptor binding domainWanwisa Dejnirattisai, Daming Zhou, Helen M Ginn, et al.Nature Communications|March 30, 2021
A haemagglutination test for rapid detection of antibodies to SARS-CoV-2Alain Townsend, Pramila Rijal, Julie Xiao, et al.Cell|July 9, 2021
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serumChang Liu, Helen M Ginn, Wanwisa Dejnirattisai, et al.Pageof 3